Cleared Traditional

K992699 - NIPRO BLOOD COLLECTION NEEDLE

K992699 is an FDA 510(k) clearance for NIPRO BLOOD COLLECTION NEEDLE, manufactured by Nipro Medical Corp.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 186-day FDA review.

K992699 · Nipro Medical Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2000
Decision
186d
Days
Class 2
Risk

K992699 is an FDA 510(k) clearance for the NIPRO BLOOD COLLECTION NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Nipro Medical Corp. (Lexington, US). The FDA issued a Cleared decision on February 14, 2000 after a review of 186 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Nipro Medical Corp. devices

FDA 510(k) Submission Details - K992699

510(k) Number K992699 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 1999
Decision Date February 14, 2000
Days to Decision 186 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d slower than avg
Panel avg: 129d · This submission: 186d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 494
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K992699.
BODYGUARD
K000441 · Vital Signs, Inc. · Apr 2000
LUER ACCESS UNIVERSAL VIAL ADAPTER
K000657 · Baxter Healthcare Corp · Mar 2000
TERUMO NEEDLE WITH LOCKING SHEATH
K000387 · Terumo Medical Corp. · Mar 2000
NIPRO LUER ADAPTOR
K992729 · Nipro Medical Corp. · Jan 2000
DISENTRONIC PENFINE INJECTION PEN NEEDLE
K994197 · Disetronic Medical Systems · Dec 1999
SURE-WAY REUSABLE SHARPS CONTAINER
K992626 · Sure-Way Systems, Inc. · Dec 1999